Guerra Manuel, Haye María Teresa, Montaño Ignacio, Toro Victoria, Maiz Nerea
Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile.
Departament of Perinatology, Clínica Redsalud Vitacura. Santiago, Chile.
Am J Perinatol. 2025 Nov;42(15):2032-2037. doi: 10.1055/a-2555-3684. Epub 2025 Mar 20.
First, to explore differences in fetal cardiac function in patients with and without intrahepatic cholestasis of pregnancy (ICP) based on the TEI index. Second, to explore a potential correlation between TEI index and bile acid levels in pregnant women with ICP. Third, to study changes in the TEI index of fetuses from pregnant women with ICP after administration of ursodeoxycholic acid (UDCA).This is a prospective observational case-control study conducted at Hospital Clínico San José and Clínica RedSalud Vitacura, both in Santiago, Chile, between April 2018 and October 2020. ICP was defined as palmar-plantar pruritus of nocturnal predominance for more than 1 week associated with a total bile acid level above 10 μmol/L. Control cases were women with pregnancies scheduled for induction or elective cesarean section between 37 and 40 weeks of gestation according to current protocols. Differences in the TEI index between cases and controls were assessed by the Wilcoxon test. The correlation between the TEI index and bile acid levels was assessed by the Spearman correlation test. Changes in TEI index before and after administration of UDCA were analyzed by the paired samples Wilcoxon test.A total of 181 pregnant women were included in the study, 109 women with ICP and 72 controls. The median gestational age at inclusion was 35.9 weeks (interquartile range [IQR], 33.0-38.9). The median TEI index was 0.31 (IQR, 0.29-0.36); this was significantly longer in fetuses of women with ICP ([0.34, IQR, 0.30-0.38] vs. [0.30, IQR, 0.28-0.31], < 0.001). There was a significant correlation between bile acid levels and TEI index (0.584, < 0.001). In 21 fetuses, the TEI index was measured a second time, 2 weeks later, following UDCA administration. The median TEI index decreased significantly following UDCA administration (0.40 ms before treatment [IQR, 0.36-0.42] vs. 0.33 after treatment [IQR, 0.32-0.38], = 0.001), = 0.001).The TEI index is increased in fetuses of women with ICP. TEI index was significantly correlated with bile acid levels, and administration of UDCA significantly reduced the TEI index. · Significant correlation between TEI index and bile acid levels.. · Effect of UDCA treatment.. · clinical implications for monitoring and treatment..
首先,基于心肌性能指数(TEI指数)探讨妊娠合并肝内胆汁淤积症(ICP)患者与未患该症患者胎儿心功能的差异。其次,探讨ICP孕妇的TEI指数与胆汁酸水平之间的潜在相关性。第三,研究ICP孕妇服用熊去氧胆酸(UDCA)后胎儿TEI指数的变化。
这是一项前瞻性观察性病例对照研究,于2018年4月至2020年10月在智利圣地亚哥的圣何塞临床医院和维塔库拉红 Salud 诊所进行。ICP定义为夜间为主的掌跖瘙痒超过1周,且总胆汁酸水平高于10μmol/L。对照病例为根据现行方案在妊娠37至40周计划引产或择期剖宫产的孕妇。病例组与对照组之间TEI指数的差异通过Wilcoxon检验进行评估。TEI指数与胆汁酸水平之间的相关性通过Spearman相关性检验进行评估。UDCA给药前后TEI指数的变化通过配对样本Wilcoxon检验进行分析。
共有181名孕妇纳入研究,其中109例为ICP患者,72例为对照。纳入时的中位孕周为35.9周(四分位间距[IQR],33.0 - 38.9)。中位TEI指数为0.31(IQR,0.29 - 0.36);ICP患者胎儿的该指数明显更长([0.34,IQR,0.30 - 0.38] 对比 [0.30,IQR,0.28 - 0.31],P < 0.001)。胆汁酸水平与TEI指数之间存在显著相关性(r = 0.584,P < 0.001)。在21例胎儿中,UDCA给药2周后第二次测量TEI指数。UDCA给药后,中位TEI指数显著下降(治疗前0.40毫秒 [IQR,0.36 - 0.42] 对比治疗后0.33 [IQR,0.32 - 0.38],P = 0.001)。
ICP患者胎儿的TEI指数升高。TEI指数与胆汁酸水平显著相关,且UDCA给药显著降低了TEI指数。· TEI指数与胆汁酸水平之间的显著相关性。· UDCA治疗的效果。· 监测和治疗的临床意义。